Lyme Disease Pipeline Review 2024: Clinical Trials Update and Latest FDA, EMA, and PMDA Approvals | Abbott, Bio-Rad Laboratories, Inc., Covance Inc.F. Hoffmann-La Roche AG, T2 Biosystems, Oxford Immunotec

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Lyme Disease pipeline constitutes 7+ key companies continuously working towards developing 7+ Lyme Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

"Lyme Disease Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Lyme Disease Market.

The Lyme Disease Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

Some of the key takeaways from the Lyme Disease Pipeline Report: https://www.delveinsight.com/sample-request/lyme-disease-ld-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel Lyme Disease treatment therapies with a considerable amount of success over the years.
• Lyme Disease companies working in the treatment market are CyanVac, Flightpath Biosciences, Inc, Cortene Inc., Tarsus Pharmaceuticals, Inc, Valneva SE, and others, are developing therapies for the Lyme Disease treatment
• Emerging Lyme Disease therapies in the different phases of clinical trials are- BLB 400, FP-100, CT38, TP-05, VLA15, and others are expected to have a significant impact on the Lyme Disease market in the coming years.
• In September 2024, Valneva and Pfizer have announced positive results from the Phase II VLA15-221 clinical trial, evaluating a second booster dose of their Lyme disease vaccine candidate, VLA15, given one year after the initial booster. VLA15 is an investigational multivalent protein subunit vaccine targeting the outer surface protein A (OspA) of Borrelia burgdorferi, the bacteria responsible for Lyme disease.

Lyme Disease Overview
The most prevalent vector-borne illness, Lyme disease (also known as Lyme borreliosis), is brought on by the bacteria Borrelia burgdorferi and, less frequently, Borrelia mayonii. It is a prevalent illness in the United States that is brought on by the bite of an infected blacklegged tick, sometimes referred to as a bear or deer tick. The illness impacts both people and animals.

Get a Free Sample PDF Report to know more about Lyme Disease Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/lyme-disease-ld-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Emerging Lyme Disease Drugs Under Different Phases of Clinical Development Include:
• BLB 400: CyanVac
• FP-100: Flightpath Biosciences, Inc
• CT38: Cortene Inc.
• TP-05: Tarsus Pharmaceuticals, Inc
• VLA15: Valneva SE

Lyme Disease Route of Administration
Lyme Disease pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Oral
• Parenteral
• Intravenous
• Subcutaneous
• Topical

Lyme Disease Molecule Type
Lyme Disease Products have been categorized under various Molecule types, such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy

Lyme Disease Pipeline Therapeutics Assessment
• Lyme Disease Assessment by Product Type
• Lyme Disease By Stage and Product Type
• Lyme Disease Assessment by Route of Administration
• Lyme Disease By Stage and Route of Administration
• Lyme Disease Assessment by Molecule Type
• Lyme Disease by Stage and Molecule Type

DelveInsight's Lyme Disease Report covers around 5+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration

Further Lyme Disease product details are provided in the report. Download the Lyme Disease pipeline report to learn more about the emerging Lyme Disease therapies at:
https://www.delveinsight.com/sample-request/lyme-disease-ld-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key companies in the Lyme Disease Therapeutics Market include:
Key companies developing therapies for Lyme Disease are - Abbott, Bio-Rad Laboratories, Inc., Covance Inc.F. Hoffmann-La Roche AG, T2 Biosystems, Inc, Oxford Immunotec USA, Inc., and others.

Lyme Disease Pipeline Analysis:
The Lyme Disease pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Lyme Disease with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Lyme Disease Treatment.
• Lyme Disease key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Lyme Disease Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Lyme Disease market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Download Sample PDF Report to know more about Lyme Disease drugs and therapies-
https://www.delveinsight.com/sample-request/lyme-disease-ld-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Lyme Disease Pipeline Market Drivers
• Increasing Prevalence of Lyme disease, development in studies on the treatment of Lyme disease are some of the important factors that are fueling the Lyme Disease Market.

Lyme Disease Pipeline Market Barriers
• However, lack of pipeline therapies, risk for significant long-term health consequences and other factors are creating obstacles in the Lyme Disease Market growth.

Scope of Lyme Disease Pipeline Drug Insight
• Coverage: Global
• Key Lyme Disease Companies: CyanVac, Flightpath Biosciences, Inc, Cortene Inc., Tarsus Pharmaceuticals, Inc, Valneva SE, and others
• Key Lyme Disease Therapies: BLB 400, FP-100, CT38, TP-05, VLA15, and others
• Lyme Disease Therapeutic Assessment: Lyme Disease current marketed and Lyme Disease emerging therapies
• Lyme Disease Market Dynamics: Lyme Disease market drivers and Lyme Disease market barriers

Request for Sample PDF Report for Lyme Disease Pipeline Assessment and clinical trials-
https://www.delveinsight.com/sample-request/lyme-disease-ld-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Lyme Disease Report Introduction
2. Lyme Disease Executive Summary
3. Lyme Disease Overview
4. Lyme Disease- Analytical Perspective In-depth Commercial Assessment
5. Lyme Disease Pipeline Therapeutics
6. Lyme Disease Late Stage Products (Phase II/III)
7. Lyme Disease Mid Stage Products (Phase II)
8. Lyme Disease Early Stage Products (Phase I)
9. Lyme Disease Preclinical Stage Products
10. Lyme Disease Therapeutics Assessment
11. Lyme Disease Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Lyme Disease Key Companies
14. Lyme Disease Key Products
15. Lyme Disease Unmet Needs
16 . Lyme Disease Market Drivers and Barriers
17. Lyme Disease Future Perspectives and Conclusion
18. Lyme Disease Analyst Views
19. Appendix
20. About DelveInsight

Related Reports:

Lyme Disease Market https://www.delveinsight.com/report-store/lyme-disease-ld-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Lyme Disease Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),

Lyme Disease Epidemiology https://www.delveinsight.com/report-store/lyme-disease-ld-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Lyme Disease Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Latest Reports Offered By DelveInsight:

Ventricular Assist Devices Market https://www.delveinsight.com/report-store/ventricular-assist-devices-vad-market
Ventricular Assist Devices Market By Product Type (Left Ventricular Assist Devices, Right Ventricular Assist Devices, And Biventricular Assist Devices), By Application Type (Bridge-To-Transplant [Btt], Destination Therapy, And Others), By Design Type (Transcutaneous Ventricular Assist Devcies And Implantable Ventricular Assist Devices), By Type Of Flow (Pulsatile Flow And Continous Flow), By End User (Hospital And Clinics, Ambulatory Surgical Centers, And Others), by geography is expected to grow at a steady CAGR forecast till 2028 owing to the increasing prevalence of heart failure and cardiovascular diseases due to obesity, age, & unhealthy lifestyles and rising demand for organ transplants due to increasing prevalence of chronic ailments such as hypertension, diabetes, and others

B-cell Non-hodgkin Lymphoma Market https://www.delveinsight.com/report-store/b-cell-non-hodgkin-lymphoma-market
DelveInsight's "B-Cell Non-Hodgkin Lymphoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the B-Cell Non-Hodgkin Lymphoma, historical and forecasted epidemiology as well as the B-Cell Non-Hodgkin Lymphoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Systemic Sclerosis Market
https://www.delveinsight.com/report-store/systemic-sclerosis-market
DelveInsight's "Systemic Sclerosis Market Insights, Epidemiology, and Market Forecast - 2032" comprehensively analyzes Systemic Sclerosis. The report includes a detailed examination of the historical and projected epidemiology data that includes diagnosed prevalent cases of Systemic Sclerosis segmented by gender-specific, age-specific, and type-specific cases.

Resorbable Vascular Scaffold Market
https://www.delveinsight.com/report-store/resorbable-vascular-scaffolds-market
"DelveInsight's 'Resorbable Vascular Scaffolds Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Resorbable Vascular Scaffolds and the historical and forecasted Resorbable Vascular Scaffolds market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Vascular Stents Market
https://www.delveinsight.com/report-store/vascular-stents-market
Vascular Stents Market By Product Type (Coronary Stents, Peripheral Stents [Carotid Stents, Iliac Stents, Femoral Stents, Femoral Stents, Other], Evar Stent Grafts [Abdominal Aortic Aneurysm Stents, Thoracic Aortic Aneurysm Stents]), By Type (Bare-Metal Stents, Drug-Eluting Stents), By Material (Metal And Polymer), By Mode Of Delivery (Balloon-Expandable Stents And Self Expandable Stents), By End-User (Hospitals And Ambulatory Surgical Centers), by geography, is expected to grow at a noteworthy CAGR forecast till 2028 owing to rising burden of vascular diseases across the globe and increasing preferences of minimally invasive surgeries among the patient population.

Bladder Scanners Market
https://www.delveinsight.com/report-store/bladder-scanners-market
"DelveInsight's 'Bladder Scanners Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Bladder Scanners and the historical and forecasted Bladder Scanners market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Vein Illumination Devices Market
https://www.delveinsight.com/report-store/vein-illumination-devices-market
"DelveInsight's 'Vein Illumination Devices Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Vein Illumination Devices and the historical and forecasted Vein Illumination Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Ventilator Market
https://www.delveinsight.com/report-store/ventilators-market
Ventilators Market By Mobility (Intensive Care Ventilators, Portable/Transportable Ventilators), By Type (Adult/Pediatric Ventilators, Neonatal/Infant Ventilators), By Interface (Invasive Ventilation, Non-Invasive Ventilation), By End-User (Hospitals, Home Care, Ambulatory Surgical Centers, Others), By Geography is expected to grow at a steady CAGR forecast till 2028 owing to launch of advanced devices and increasing prevalence of respiratory diseases such as COPD.

Vascular Graft Devices Market
https://www.delveinsight.com/report-store/vascular-grafts-market
Vascular Graft Devices Market By Product Type (Endovascular Grafts [Abdominal And Thoracic], Access Grafts, Peripheral Grafts, And Others), By Type (Knitted, Woven, And Others), By Material (Synthetic[ Polytetrafluoroethylene [PTFE], Polyester, Polyurethane], Biological, And Others), By End User (Hospitals, Ambulatory Surgical Centers, And Others), by geography is expected to register commendable revenue growth at a steady CAGR forecast till 2028 owing to increasing prevalence of cardiovascular diseases such as aortic aneurysms and peripheral artery disease and growing patient for kidney dialysis.

Patient Monitoring Devices Market
https://www.delveinsight.com/report-store/patient-monitoring-devices-market
Patient Monitoring Devices Market By Type Of Devices (Neuromonitoring Devices, Cardiac Monitoring Devices, Respiratory Monitoring Devices, Hemodynamic Monitoring Devices, Blood Glucose Monitoring Systems, And Others), By Application (Cardiology, Neurology, Respiratory, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings, And Others), by geography, is anticipated to grow at a significant CAGR till 2028 owing to the growing prevalence of various chronic disorders and integration of advanced technology in the products.

Symptomatic Partial-thickness Rotator Cuff Tears Market
https://www.delveinsight.com/report-store/symptomatic-partial-thickness-rotator-cuff-tears-market
DelveInsight's "Symptomatic Partial-thickness Rotator Cuff Tears Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Symptomatic Partial-thickness Rotator Cuff Tears, historical and forecasted epidemiology as well as the Symptomatic Partial-thickness Rotator Cuff Tears market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Zika Virus Market
https://www.delveinsight.com/report-store/zika-virus-market
DelveInsight's "Zika Virus Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Zika Virus, historical and forecasted epidemiology as well as the Zika Virus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Contact Us:
Gaurav Bora
gbora@delveinsight.com
+14699457679
Healthcare Consulting
https://www.delveinsight.com/consulting-services

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

This release was published on openPR.